https://www.selleckchem.com/pr....oducts/bgb-16673.htm
The primary outcome for assessing preliminary effectiveness is a mean score across five key symptoms that are amenable to change (ie, breathlessness, pain, anxiety, constipation, fatigue), measured at baseline and 8 weeks post-baseline. The process evaluation will be conducted in the intervention group only, with measurements at 8-11 weeks post-baseline to evaluate implementation, mechanisms of change and contextual factors. The study has been approved by the ethics committee of University Hospital Ghent. Results will be used to infor
Gefällt mir
Kommentar
Teilen
